Letter to the editor (multiple letters) [1]

Lancet

Volumn 353, Issue 9162, 1999, Pages 1439-1440

  Tustin, T ^a   Russell, R I ^a  

^a Surrey Research Park   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; ETODOLAC; IBUPROFEN; MELOXICAM; NAPROXEN; NIMESULIDE; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; ROFECOXIB; UNCLASSIFIED DRUG; CYCLOOXYGENASE 2; ISOENZYME; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PEROXIDASE;

DIGESTIVE SYSTEM ULCER; DRUG SAFETY; DRUG SELECTIVITY; GASTROINTESTINAL HEMORRHAGE; HUMAN; LETTER; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RHEUMATOID ARTHRITIS; METABOLISM; NOTE; DRUG ANTAGONISM;

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; ISOENZYMES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PEROXIDASES;

EID: 0033599770     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. CJ Hawkey COX-2 inhibitors Lancet 353 1999 307 314
2. D Riendeau MD Percival S Boyce Biochemical and pharmacological profile of tetrasubstituted furanone as a highly selective COX-2 inhibitor Br J Pharmacol 121 1997 105 117
3. D Riendeau S Charleston N Cromlish JA Mancini E Wong J Guay Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays Can J Physiol Pharmacol 75 1997 1088 1095
4. JD Arnold lL Salom AE Berger Comparison of gastrointesinal microbleeding associated with use of etodolac, ibuprofen, indomethacin, and naproxen in normal subjects Curr Therapeut Res 37 1985 730 738
5. DH Neustadt Double blind evaluation of the longterm effects of etodolac versus ibuprofen in patients with rheumatoid arthritis J Rheumatol 24 suppl 47 1997 17 22